Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 111

1.

Complications in patients after intravitreal injection of bevacizumab.

Shima C, Sakaguchi H, Gomi F, Kamei M, Ikuno Y, Oshima Y, Sawa M, Tsujikawa M, Kusaka S, Tano Y.

Acta Ophthalmol. 2008 Jun;86(4):372-6. Epub 2007 Nov 17.

PMID:
18028234
[PubMed - indexed for MEDLINE]
2.

Twelve-month safety of intravitreal injections of bevacizumab (Avastin): results of the Pan-American Collaborative Retina Study Group (PACORES).

Wu L, Martínez-Castellanos MA, Quiroz-Mercado H, Arevalo JF, Berrocal MH, Farah ME, Maia M, Roca JA, Rodriguez FJ; Pan American Collaborative Retina Group (PACORES).

Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):81-7. Epub 2007 Aug 3.

PMID:
17674014
[PubMed - indexed for MEDLINE]
3.

A one-year follow-up study of ocular and systemic complications of intravitreal injection of bevacizumab (Avastin).

Fasih U, Shaikh N, Rahman A, Sultan S, Fehmi MS, Shaikh A.

J Pak Med Assoc. 2013 Jun;63(6):707-10.

PMID:
23901669
[PubMed - indexed for MEDLINE]
4.

[Retinal pigment epithelial tears after intravitreal injection of bevacizumab for AMD. Frequency and progress].

Kook D, Wolf A, Neubauer AS, Haritoglou C, Priglinger SG, Kampik A, Ulbig MW.

Ophthalmologe. 2008 Feb;105(2):158-64. German.

PMID:
17653552
[PubMed - indexed for MEDLINE]
5.

Intravitreal bevacizumab (Avastin) for occult choroidal neovascularization in age-related macular degeneration.

Aisenbrey S, Ziemssen F, Völker M, Gelisken F, Szurman P, Jaissle G, Grisanti S, Bartz-Schmidt KU.

Graefes Arch Clin Exp Ophthalmol. 2007 Jul;245(7):941-8. Epub 2006 Dec 21.

PMID:
17186262
[PubMed - indexed for MEDLINE]
6.

Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.

Chan CK, Meyer CH, Gross JG, Abraham P, Nuthi AS, Kokame GT, Lin SG, Rauser ME, Kaiser PK.

Retina. 2007 Jun;27(5):541-51.

PMID:
17558314
[PubMed - indexed for MEDLINE]
7.

Retinal pigment epithelial tear after intravitreal bevacizumab injection.

Shah CP, Hsu J, Garg SJ, Fischer DH, Kaiser R.

Am J Ophthalmol. 2006 Dec;142(6):1070-2. Epub 2006 Sep 12.

PMID:
17157598
[PubMed - indexed for MEDLINE]
8.

Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.

Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A.

Retina. 2007 Apr-May;27(4):432-8.

PMID:
17420694
[PubMed - indexed for MEDLINE]
9.

The International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwide.

Fung AE, Rosenfeld PJ, Reichel E.

Br J Ophthalmol. 2006 Nov;90(11):1344-9. Epub 2006 Jul 19.

PMID:
16854824
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Intravitreal injection of triamcinolone combined with bevacizumab for choroidal neovascularization associated with large retinal pigment epithelial detachment in age-related macular degeneration.

el Matri L, Chebil A, Kort F, Bouraoui R, Baklouti K, Mghaieth F.

Graefes Arch Clin Exp Ophthalmol. 2010 Jun;248(6):779-84. doi: 10.1007/s00417-010-1302-4. Epub 2010 Feb 19.

PMID:
20169357
[PubMed - indexed for MEDLINE]
11.

Primary intravitreal bevacizumab for subfoveal choroidal neovascularization in age-related macular degeneration: results of the Pan-American Collaborative Retina Study Group at 12 months follow-up.

Arevalo JF, Fromow-Guerra J, Sanchez JG, Maia M, Berrocal MH, Wu L, Saravia MJ, Costa RA; Pan-American Collaborative Retina Study Group.

Retina. 2008 Nov-Dec;28(10):1387-94. doi: 10.1097/IAE.0b013e3181884ff4.

PMID:
18827735
[PubMed - indexed for MEDLINE]
12.

Surveillance for potential adverse events associated with the use of intravitreal bevacizumab for retinal and choroidal vascular disease.

Wong LJ, Desai RU, Jain A, Feliciano D, Moshfeghi DM, Sanislo SR, Blumenkranz MS.

Retina. 2008 Oct;28(8):1151-8. doi: 10.1097/IAE.0b013e31817e100f.

PMID:
18685542
[PubMed - indexed for MEDLINE]
13.

Retinal pigment epithelium tears after intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

Ronan SM, Yoganathan P, Chien FY, Corcóstegui IA, Blumenkranz MS, Deramo VA, Elner SG, Fastenberg DA, Johnson MW, López M, Mateo C, Moshfeghi DM, Navarro R, Rosenblatt BJ, Sanislo SR, Saxe SJ, Zacks DN.

Retina. 2007 Jun;27(5):535-40.

PMID:
17558313
[PubMed - indexed for MEDLINE]
14.

Severe intraocular inflammation after intravitreal injection of bevacizumab.

Sato T, Emi K, Ikeda T, Bando H, Sato S, Morita S, Oyagi T, Sawada K.

Ophthalmology. 2010 Mar;117(3):512-6, 516.e1-2. doi: 10.1016/j.ophtha.2009.07.041. Epub 2010 Jan 19.

PMID:
20031229
[PubMed - indexed for MEDLINE]
15.

Sterile endophthalmitis after intravitreal injection of bevacizumab obtained from a single batch.

Yamashiro K, Tsujikawa A, Miyamoto K, Oh H, Otani A, Tamuara H, Ooto S, Sasahara M, Iwama D, Yoshimura N.

Retina. 2010 Mar;30(3):485-90. doi: 10.1097/IAE.0b013e3181bd2d51.

PMID:
19952993
[PubMed - indexed for MEDLINE]
16.

Retinal pigment epithelial tear following intravitreal injection of bevacizumab (Avastin).

Nicolò M, Ghiglione D, Calabria G.

Eur J Ophthalmol. 2006 Sep-Oct;16(5):770-3.

PMID:
17061236
[PubMed - indexed for MEDLINE]
17.

Acute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age-related macular degeneration.

Wickremasinghe SS, Michalova K, Gilhotra J, Guymer RH, Harper CA, Wong TY, Qureshi S.

Ophthalmology. 2008 Nov;115(11):1911-5. doi: 10.1016/j.ophtha.2008.05.007. Epub 2008 Jul 31.

PMID:
18672291
[PubMed - indexed for MEDLINE]
18.

Submacular haemorrhage after intravitreal bevacizumab compared with intravitreal ranibizumab in large occult choroidal neovascularization.

Krishnan R, Goverdhan S, Lochhead J.

Clin Experiment Ophthalmol. 2009 May;37(4):384-8. doi: 10.1111/j.1442-9071.2009.02043.x.

PMID:
19594565
[PubMed - indexed for MEDLINE]
19.

Assessment of anterior chamber inflammation after intravitreal bevacizumab injection in different ocular exudative diseases.

Yeniad B, Ayranci O, Tuncer S, Kir N, Ovali T, Tugal-Tutkun I, Akarcay K.

Eur J Ophthalmol. 2011 Mar-Apr;21(2):156-61.

PMID:
20658459
[PubMed - indexed for MEDLINE]
20.

Short-term safety and efficacy of intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration.

Rich RM, Rosenfeld PJ, Puliafito CA, Dubovy SR, Davis JL, Flynn HW Jr, Gonzalez S, Feuer WJ, Lin RC, Lalwani GA, Nguyen JK, Kumar G.

Retina. 2006 May-Jun;26(5):495-511.

PMID:
16770255
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk